Apr 2019 $18 M No. 5 $10 to $50 million 99
Shine Medical Technologies, Inc.: Raise no. 5, Apr 2019 × Investors in this round 99 investors had bought by the notice of Jun 28, 2019: 99 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $30 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anton M. Asmuth · Executive Officer, Director Gregory Richard Piefer · Executive Officer, Director Harsh M. Singh · Executive Officer Katrina M. Pitas · Executive Officer Steve M. Miltenberger · Executive Officer Brad M. Wucherpfennig · Director Gordon M. Gunnlaugsson · Director Gregory M. Smith · Director Philip M. Halpern · Director Thomas Rockwell Mackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anton Asmuth, Chief Financial Officer. Newest notice filed Jun 28, 2019. Read the notice at the SEC .
equity, options SEC Apr 2018 $18 M No. 4 $10 to $50 million 122
Shine Medical Technologies, Inc.: Raise no. 4, Apr 2018 × Investors in this round 122 investors had bought by the notice of Nov 29, 2018: 122 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $25 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anton M. Asmuth · Executive Officer, Director Gregory Richard Piefer · Executive Officer, Director Steve M. Miltenberger · Executive Officer Brad M. Wucherpfennig · Director Gordon M. Gunnlaugsson · Director Gregory M. Smith · Director Philip M. Halpern · Director Thomas Rockwell Mackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anton Asmuth, Chief Financial Officer. Newest notice filed Nov 29, 2018. Read the notice at the SEC .
equity, options SEC Aug 2017 $7 M No. 3 $2 to $10 million 26
Shine Medical Technologies, Inc.: Raise no. 3, Aug 2017 × Investors in this round 26 investors had bought by the notice of Sep 6, 2017: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $16 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $155,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Wisconsin People named in the notice Anton M. Asmuth · Executive Officer, Director Darin Richard Janecek · Executive Officer Gregory Richard Piefer · Executive Officer, Director Donald M. Whelley · Director Gregory M. Smith · Director Philip M. Halpern · Director Richard H. Leazer · Director Thomas Rockwell Mackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, Minnesota Sold in CA, CO, FL, IL, NC, NE, NY, WI Signed by Darin Janecek, Chief Financial Officer. Newest notice filed Sep 6, 2017. Read the notice at the SEC .
debt, options SEC Oct 2013 $29 M No. 2 $10 to $50 million 217
Shine Medical Technologies, Inc.: Raise no. 2, Oct 2013 × Investors in this round 217 investors had bought by the notice of Apr 3, 2017: 217 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $29 M of $30 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $300,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Wisconsin People named in the notice Anton M. Asmuth · Executive Officer, Director Darin Richard Janecek · Executive Officer Gregory Richard Piefer · Executive Officer, Director James M. Costedio · Executive Officer Katrina M. Pitas · Executive Officer Donald M. Whelley · Director Philip M. Halpern · Director Richard H. Leazer · Director Thomas Rockwell Mackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, Minnesota Sold in CA, CO, FL, IL, NC, NE, NY, WI Signed by Darin Janecek, Chief Financial Officer. Newest notice filed Apr 3, 2017 (2 amendments). Read the notice at the SEC .
debt, options SEC Dec 2010 $11 M No. 1 $10 to $50 million 15
Shine Medical Technologies, Inc.: Raise no. 1, Dec 2010 × Investors in this round 15 investors had bought by the notice of Oct 19, 2012: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, other: Conversion of Debt to Equity and Sale of Additional Equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $256,310 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Wisconsin People named in the notice Gregory Richard Piefer · Executive Officer, Director, Promoter Stephen Clermont Hathaway · Executive Officer, Promoter Christopher H. Manuele · Director Donald H. Whelley · Director Fred H. Mancheski · Director Richard Clermont Vann Bynum · Director Richard H. Leazer · Director Thomas Rockwell Mackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gregory R. Piefer, Chief Executive Officer. Newest notice filed Oct 19, 2012 (2 amendments). Read the notice at the SEC .
equity, debt SEC